NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Cross Above 50-Day Moving Average of $0.00

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY)’s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $2.63. NovaBay Pharmaceuticals shares last traded at $2.30, with a volume of 280,262 shares changing hands.

NovaBay Pharmaceuticals Trading Down 10.5 %

The firm has a market cap of $9.68 million, a P/E ratio of -0.23 and a beta of 2.82.

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) last issued its quarterly earnings data on Thursday, May 9th. The biopharmaceutical company reported ($0.14) EPS for the quarter. NovaBay Pharmaceuticals had a negative return on equity of 146.20% and a negative net margin of 79.70%. The company had revenue of $2.63 million during the quarter. On average, equities analysts expect that NovaBay Pharmaceuticals, Inc. will post -2.54 EPS for the current year.

About NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.